Company / Working Capital per Share
Cullinan Therapeutics, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.56
FY2024
5-year range
$6.56 / $10.88
FY2020-FY2024
Trend
-39.7%
vs FY2023
Sector context
#85 of 210
Health Care
What the data says
At $6.56, Cullinan Therapeutics, Inc.'s working capital per share ranks #85 of 210 in the Health Care sector. Declined from $9.87 to $6.56 over the past 2 years.
Based on SEC 10-K filings.
6.56 in FY2024 with a 3-year CAGR of -11.7%.
Declined from $9.87 to $6.56 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -11.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 210 in Health CareTop 40% of 210This company $6.56 Sector average $146.89
▼
-95.5% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 39.7% year-over-year.
- Ranks #85 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.56 | -39.7% |
| FY2023 | $10.88 | +10.2% |
| FY2022 | $9.87 | +3.4% |
| FY2021 | $9.55 | -4.1% |
| FY2020 | $9.95 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026